AI in drug discovery, predictive models, and biomarker identification.
Published in Nature (2024) – Blocking IL‑11 extended mouse lifespan by 22-25% (both sexes), reduced frailty, improved metabolism. Now in human Phase II trials (Boehringer Ingelheim, Calico/Mabwell) for fibrosis and scarring — not yet aging. Caveats: Mouse data promising; human longevity data years away.